Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (KCT0012348) titled 'Human Clinical Trial to Evaluate the Efficacy and Safety of KBH-HM01 in improving immune function' on July 28.

Study Type: Interventional Study

Study Design: Primary Purpose : Supportive Care, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: KolmarBNH

Condition:

Not Applicable

Intervention: Dietary Supplement : Eat test food (KBH-HM01) or placebo twice daily, once a sachet for 12 weeks.

Recruitment Status: Not Recruiting

Phase: Not applicable

Date of First Enrollment: 2024-02-06

Target Sample Size: 130

Countries of Recru...